Your healthcare provider will consider these possibilities through careful history-taking, examination, and appropriate investigations to determine the cause of your symptoms and guide management decisions
1 Select confirmatory secondary endpoints included number of participants achieving 10%, 15%, 20% and 25% weight loss, with semaglutide 7.2 mg vs placebo (and for greater than or equal to 20% and 25%, semaglutide 7.2 mg vs semaglutide 2.4 mg)
During the subacute and chronic phases, astrocytes, microglia, macrophages, endothelial cells, pericytes, oligodendrocytes, and surviving neurons continue to remodel substrate utilization
3 16.7% estimated difference between Wegovy (-16.1%) and placebo (+0.6%) at 68 weeks 3 BMI Reduction Thresholds More patients achieved BMI reductions at multiple thresholds with Wegovy injection at week 68 3 Estimated proportion of patients (%) with BMI reduction at week 68 3 Mean baseline BMI: Wegovy =37.7 kg/m 2
It results in a higher percentage of degraded RBCs, thereby reducing the RBC count and causing anemia during sepsis (eryptotic RBCs were degraded and cleared from circulation) [202, 230, 380]